Polymorphisms of TGF-beta1 in cystic fibrosis patients

被引:46
作者
Brazova, Jitka
Sismova, Kristyna
Vavrova, Vera
Bartosova, Jana
Macek, Milan, Jr.
Lauschman, Hynek
Sediva, Anna
机构
[1] Charles Univ Prague, Univ Hosp Motol, Inst Immunol, Prague 15006 5, Czech Republic
[2] Charles Univ Prague, Univ Hosp Motol, Dept Paediat, Prague 15006 5, Czech Republic
[3] Charles Univ Prague, Univ Hosp Motol, Inst Biol & Med Genet, Prague 15006 5, Czech Republic
[4] Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-16635 Prague, Czech Republic
关键词
cystic fibrosis (CF); cytokines; transforming growth; factor betal (TGF-beta1); polymorphism;
D O I
10.1016/j.clim.2006.08.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is a significant phenotypic variance among cystic fibrosis (CF) patients. Due to the rote of TGF-beta 1 in fibrotic processes we investigated its role in CF pathogenesis. TGF-beta 1 codons 10 and 25 were genotyped in 118 Czech CF patients and 268 controls by PCR-ARMS. Difference between CF and controls was found at codon 10, lower frequency of T/T homozygotes, and codon 25, higher frequency of G/C heterozygotes. We did not prove the association of TGF-beta 1 polymorphisms and lung function in CF, however, the TT (codon 10)/GG (codon 25) genotype was preferentially associated with CF-related liver disease and diabetes. Independent of the TGF-beta 1 genotype, production of cytokine was higher in patients than in controls with the notable exception of very low levels in Burkholderia cepacia complex colonized patients. In CF, both extremes, highest or lowest TGF-beta 1 production, were associated with impaired lung function. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:350 / 357
页数:8
相关论文
共 50 条
[1]  
Acton J D, 2001, Paediatr Respir Rev, V2, P332, DOI 10.1053/prrv.2001.0168
[2]   TRANSFORMING GROWTH-FACTOR-BETA AS A PREDICTOR OF LIVER AND LUNG FIBROSIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADVANCED BREAST-CANCER [J].
ANSCHER, MS ;
PETERS, WP ;
REISENBICHLER, H ;
PETROS, WP ;
JIRTLE, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1592-1598
[3]   TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis [J].
Arkwright, PD ;
Laurie, S ;
Super, M ;
Pravica, V ;
Schwarz, MJ ;
Webb, AK ;
Hutchinson, IV .
THORAX, 2000, 55 (06) :459-462
[4]   End-organ dysfunction in cystic fibrosis - Association with angiotensin I converting enzyme and cytokine gene polymorphisms [J].
Arkwright, PD ;
Pravica, V ;
Geraghty, PJ ;
Super, M ;
Webb, AK ;
Schwarz, M ;
Hutchinson, IV .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (03) :384-389
[5]   HLA class II polymorphism in cystic fibrosis - A possible modifier of pulmonary phenotype [J].
Aron, Y ;
Polla, BS ;
Bienvenu, T ;
Dall'Ava, J ;
Dusser, D ;
Hubert, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) :1464-1468
[6]   Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation [J].
Awad, MR ;
El-Gamel, A ;
Hasleton, P ;
Turner, DM ;
Sinnott, PJ ;
Hutchinson, IV .
TRANSPLANTATION, 1998, 66 (08) :1014-1020
[7]   Transforming growth factor-β1 in autoimmune hepatitis:: correlation of liver tissue expression and serum levels with disease activity [J].
Bayer, EM ;
Herr, W ;
Kanzler, S ;
Waldmann, C ;
Zum Büschenfelde, KHM ;
Dienes, HP ;
Lohse, AW .
JOURNAL OF HEPATOLOGY, 1998, 28 (05) :803-811
[8]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[9]   The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD) [J].
Celedón, JC ;
Lange, C ;
Raby, BA ;
Litonjua, AA ;
Palmer, LJ ;
DeMeo, DL ;
Reilly, JJ ;
Kwiatkowski, DJ ;
Chapman, HA ;
Laird, N ;
Sylvia, JS ;
Hernandez, M ;
Speizer, FE ;
Weiss, ST ;
Silverman, EK .
HUMAN MOLECULAR GENETICS, 2004, 13 (15) :1649-1656
[10]   Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung [J].
Cohen, JC ;
Larson, JE .
BMC DEVELOPMENTAL BIOLOGY, 2005, 5